KMT2A and acute myeloid leukemia: We report that inhibition of SRPK1 using gRNA or the specific inhibitor SPHINX316 leads to cell cycle arrest, leukemic cell differentiation, and prolonged survival of immunocompromised mice transplanted with MLL-rearranged AML cells.